INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 368 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2024. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Deep Track Capital, LP | 1,548,252 | $98,035,317 | 4.54% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,198,971 | $75,918,844 | 4.06% |
SILVERARC CAPITAL MANAGEMENT, LLC | 198,723 | $12,583,140 | 3.89% |
DCF Advisers, LLC | 107,157 | $6,785,181 | 3.58% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,856 | $11,182,605 | 3.40% |
Vahanian & Associates Financial Planning Inc. | 15,217 | $963,540 | 3.05% |
Bellevue Group AG | 3,201,800 | $202,737,976 | 2.89% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $18,996,000 | 2.80% |
Nicholas Investment Partners, LP | 499,503 | $31,628,530 | 2.16% |
Hood River Capital Management LLC | 839,130 | $53,134,000 | 1.58% |